Matching slides 110,539
Current window 90,901-90,930
Pages 3,685
Rows per page 30
Component: Listclear collectionreset all

Component

90,901-90,930 of 110,539

filter-aware
06
Uses a process diagram to illustrate the transition from cold to hot tumor states via viral infection.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
12
The slide uses a process-flow layout to show the trial design and its validation through publications and follow-up trials.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
13
Data table presents ORR, Duration of Response, CA-125 response, PFS, and OS across patient subgroups.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
14
Waterfall plot and spider plot showing patient-level clinical outcomes.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
15
The slide uses a series of bar charts to compare PFS across multiple treatment regimens for three specific patients (15B-01, 15B-15, 15B-17).Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
16
Kaplan-Meier survival curve showing superior performance of VIRO-15 compared to historical 4th line treatment data.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
17
The chart compares cross-trial data; the footnote explicitly warns against direct comparison due to protocol differences.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
18
The slide outlines a clinical trial protocol for Olvi-Vec in ovarian cancer.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
19
Includes Kaplan-Meier survival curves and dose escalation scatter plots for two distinct patient groups.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
20
Includes specific patient case reports (Pt #21A-06 and Pt #21A-04) as evidence of efficacy.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
22
The slide highlights a strategic partnership, funding, and commercial rights split between US and Greater China markets.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
23
The slide highlights a combination therapy approach involving oncolytic immunotherapy and adoptive cell therapy.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
24
The slide uses a map of the US as a background to anchor the market sizing to a specific geography.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
25
The slide highlights physical assets and operational capacity.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
27
The slide categorizes the platform's capabilities into therapeutic genes, immune modularity, and therapeutic antibodies, emphasizing non-GMO status and GLP tox readiness.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
29
The slide uses a grid layout to categorize team members into three distinct groups: Executive Team, Board of Directors, and Operations & R&D.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
30
The slide uses a combination of a checklist for past achievements and a timeline arrow for future goals.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
31
Includes footnotes regarding market close date and specific financing obligations.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
34
The slide lists key advisors, some of whom also hold executive roles (CEO, CMO, CFO) within the company.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
35
Includes microscopic imagery of patient samples (Pt.#15A-01 and Pt.#15A-11) showing longitudinal progression of treatment.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
37
The slide uses a combination of a bar chart (ELISPOT data) and a line chart (SLD over time) to show clinical efficacy.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
01
Slide 1
Includes list of geographic locations and KBW branding.Hanmi Financial | Results Presentation Deck | 48 slides · Hanmi Financial
Conference presentation Investor relations 1 hit
04
Hanmi Financial | Results Presentation Deck | 48 slidesHanmi Financial | Results Presentation Deck | 48 slides · Hanmi Financial
Conference presentation Investor relations 1 hit
09
Hanmi Financial | Results Presentation Deck | 48 slidesHanmi Financial | Results Presentation Deck | 48 slides · Hanmi Financial
Conference presentation Investor relations Beat · Solution1 hit
10
The slide includes detailed footnotes regarding specific loan categories.Hanmi Financial | Results Presentation Deck | 48 slides · Hanmi Financial
Conference presentation Investor relations Beat · Solution1 hit
19
The slide provides a snapshot of the office loan portfolio as of September 30, 2023.Hanmi Financial | Results Presentation Deck | 48 slides · Hanmi Financial
Conference presentation Investor relations Beat · Solution1 hit
20
The slide provides a donut chart of portfolio composition and a list of credit quality metrics.Hanmi Financial | Results Presentation Deck | 48 slides · Hanmi Financial
Conference presentation Investor relations Beat · Solution1 hit
21
The slide provides a breakdown of the retail segment by state and key performance indicators like DCR, LTV, and asset quality.Hanmi Financial | Results Presentation Deck | 48 slides · Hanmi Financial
Conference presentation Investor relations Beat · Solution1 hit
22
Includes footnotes detailing portfolio composition and regulatory definitions.Hanmi Financial | Results Presentation Deck | 48 slides · Hanmi Financial
Conference presentation Investor relations Beat · Solution1 hit
29
The chart combines a stacked bar chart for expense components with a line chart for the noninterest expense/average assets ratio.Hanmi Financial | Results Presentation Deck | 48 slides · Hanmi Financial
Conference presentation Investor relations Beat · Market Size1 hit